Shanxi Lanhua Pharmaceutical

Shanxi Lanhua Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company and a key subsidiary of the Shanxi Lanhua Sci-Tech Venture Group. The company specializes in the research, development, and large-scale manufacturing of chemical generic drugs, traditional Chinese medicines (TCM), and active pharmaceutical ingredients (APIs). Its extensive product portfolio includes antibiotics, metabolic treatments, and cardiovascular medications, with well-known products such as Norfloxacin and Metformin. Operating multiple GMP-certified production lines, the company focuses on various dosage forms including tablets, capsules, and granules. Shanxi Lanhua Pharmaceutical serves as a significant regional player in the Chinese healthcare market, integrating traditional herbal expertise with modern chemical drug production.